Rajaram's claim is that deep tech fails the test venture capital normally applies — replicability. There is no playbook that carries from an EV company to a battery company to a quantum-security company, only pages with a huge standard deviation between them, so founders and investors alike have to underwrite each silo on its own physics and its own clock. His filter is exponential rather than incremental: an efficiency gain in the tens of percent is an engineering project, a few-hundred-percent change in the problem statement is deep tech, and the gross margin should eventually land at 50–70% rather than 10–15% to make the wait worthwhile. Speciale is a seed fund comfortable entering at lab scale and underwriting the scale-up risk, which is why 30 to 40 hours go into the founders' background before the technology does. Around that sit his other arguments: capital chased fintech and e-commerce first because those markets were obvious and deep tech's are not — Indian space was pegged near $8 billion four years ago and $100 billion two weeks before taping. India's technical universities spent two decades moving from pure research to corporate IP transfer and are only now producing professor-CEOs. The country's real edge is inherited — liberalisation-era chemistry and pharma, ISRO's guard rails, an OEM manufacturing base — and his three forward bets are material science, synthetic biology and manufacturing, deliberately excluding space, robotics, quantum and semiconductors because those are already happening.
Worth your time if you are
Deep-tech founders writing their first risk timeline
Seed investors underwriting lab-to-factory scale-up
Global CVCs scoping an India office
Professors weighing a company against a lab
LPs who expect a SaaS-shaped return curve